India's First Indigenous H5N1 Bird Flu Vaccine Dedicated to the Nation: Rs 1-2 Per Dose, Developed by ICAR-NIHSAD Bhopal Scientists

India on November 20, 2026 got its first indigenous chicken vaccine against Avian Influenza (H5N1), commonly known as bird flu, when Union Minister for Agriculture and Farmers' Welfare and Rural Development Shivraj Singh Chouhan dedicated it to the nation at a programme in Bhopal. Priced at just Rs. 1-2 per dose, the vaccine is described in the PIB release as the world's first vaccine against this particular variant of bird flu. It is expected to strengthen disease prevention in the poultry sector and protect the livelihoods of millions of poultry farmers.

Key points

  1. The vaccine and the institute: The release credits scientists of the ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal with developing the vaccine, after months of continuous work under stringent biosafety protocols. The research team comprised Dr. S. Nagarajan, Dr. Manoj Kumar, Dr. C. Tosh, Dr. H. V. Murugkar, Dr. Aniket Sanyal, Dr. Senthil Kumar D., Dr. Naveen Kumar and Dr. Yogisharadhya R. The release also credits ICAR-NIHSAD, Bhopal with having earlier developed indigenous vaccines for Gumboro disease, Brucella abortus S-19 Delta, Classical Swine Fever and African Swine Fever.
  2. New Rs. 300-crore laboratory for Bhopal: On the occasion, the Minister announced a new state-of-the-art animal disease research laboratory at NIHSAD Bhopal at an estimated cost of Rs. 300 crore.
  3. Why an affordable bird flu vaccine matters: India's first bird flu outbreak was reported in 2006 at Navapur, Maharashtra, in which 10 lakh chickens died and lakhs more had to be culled to contain the infection. Around 9 lakh chickens died in 2021 and about 2 lakh this year, and the country has seen more than 500 outbreaks since 2006. The disease can also transmit to mammals and humans, so prevention protects both the poultry economy and public health.
  4. The wider animal-disease burden: The Minister highlighted that animal husbandry contributes 14 per cent to India's GDP, while the poultry sector accounts for another 1 per cent. According to figures shared by the Minister, Foot and Mouth Disease causes average annual losses of about Rs. 22,000 crore, Lumpy Skin Disease Rs. 20,000 crore, Brucellosis Rs. 9,212 crore and Peste des Petits Ruminants Rs. 4,683 crore - together roughly Rs. 56,000 crore a year. Under the National Animal Disease Control Programme, launched by Prime Minister Narendra Modi from Mathura, 147 crore 16 lakh free vaccine doses have so far been administered against FMD. Recalling the 2022 Lumpy Skin Disease outbreak, in which 32.8 lakh animals were infected and 1.86 lakh died, the release notes that scientists at Hisar and Izatnagar developed the Lumpi-ProVacInd vaccine against it.

Why this matters for UPSC aspirants

  • GS-3 (Science and Technology, Agriculture): Indigenous vaccine development shows India's capacity in high-biosafety veterinary research; ICAR-NIHSAD Bhopal is a key institute for animal disease diagnostics and vaccines.
  • GS-3 (Economy): Livestock and poultry support millions of rural livelihoods; the economics of animal disease control is a frequent Mains theme.
  • Key prelims facts: H5N1 = a subtype of Avian Influenza (bird flu); NIHSAD = National Institute of High Security Animal Diseases, Bhopal, under ICAR; NADCP = National Animal Disease Control Programme; PPR = Peste des Petits Ruminants, a sheep and goat disease; Lumpi-ProVacInd = indigenous Lumpy Skin Disease vaccine.

Official source: PIB release dated November 20, 2026 (5:53 PM)

Powered by Blogger.